We collated publicly available single-cell expression profiles of circulating tumor cells (CTCs) and showed that CTCs across cancers lie on a near-perfect continuum of epithelial to mesenchymal (EMT) transition. Integrative analysis of CTC transcriptomes also highlighted the inverse gene expression pattern between PD-L1 and MHC, which is implicated in cancer immunotherapy. We used the CTCs expression profiles in tandem with publicly available peripheral blood mononuclear cell (PBMC) transcriptomes to train a classifier that accurately recognizes CTCs of diverse phenotype. Further, we used this classifier to validate circulating breast tumor cells captured using a newly developed microfluidic systems for label-free enrichment of CTCs. 34 A staggering 90% of cancer deaths are attributable to metastases 1 . After detaching from solid 35 tumors, cancer cells travel through the bloodstream to reach distant organs and seed the development 36 of metastatic tumors 2 . Cancer cells under circulation are called circulating tumor cells (CTCs) 3 . As a 37 blood-based bio marker, CTCs offer unabated, real-time insights into tumor evolution and therapeutic 38 responses. Despite these promises, the rareness of CTCs in the peripheral blood hinders their isolation 39 and characterization 3 . Cancers in solid tissues develop from epithelial cells, which are typically densely 40 packed in layers. However, dissemination and migration of cancer cells during metastasis require the 41 acquisition of mesenchymal-like features. Transcendence of epithelial cancer cells into mesenchymal-like 42 ones is popularly known as Epithelial to Mesenchymal Transition (EMT). 43 It is widely understood that due to the loss of epithelial property only a fraction of CTCs can be 44 expected to express canonical epithelial markers such as Epithelial Cell Adhesion Molecule (EpCAM).
colleagues demonstrated the generation of a CD44 high /CD24 low , mammary stem cell-like population due to the induction of EMT. These cells were able to initiate tumors quite efficiently in the mouse. We tracked 122 expression changes in CSC markers along E-M continuum 25 . CD44 high /CD24 low CTCs indeed emerge 123 late in the spectrum, following EMT induction. (Fig 3-b ) This demonstrates how integrative analysis of 124 CTC transcriptomes can help pinpoint stem-like phenotypes, with high tumorogenesis potential.
125
CTC-PBMC classification system 126 We trained a classifier on publicly available single cell expression profiles of human CTCs and PBMCs. 127 Expression datasets curated from independent studies were subjected to rigorous data preprocessing steps 128 (Methods). Notably, the state of the art batch effect removal methods (mnnCorrect 26 and Seurat 27 ) failed 129 to improve the performance of the classification algorithms, compared to a simple median normalisation 130 baseline. We compared the performance of three classifiers -Naïve Bayes 28 , Random Forest 29 , and 131 Gradient Boosting Machine 30 . We evaluated the classifiers by holding out individual CTC and PBMC 132 datasets as test data. We also evaluated the classifiers on all CTC-PBMC data pairs (Methods). Best 133 performance was observed with Naïve Bayes, with a median accuracy recorded at ∼99% and ∼98% 134 respectively (Fig 4- 
135

Identification of CTCs captured using novel label-free microfluidic workflow 136
Existing technologies enrich CTCs with some level of contaminating white blood cells (WBCs). This To validate the workflow and the accompanying PBMC-CTC classification system, we processed 143 peripheral blood samples of three HER2-, stage IV breast cancer patients (identified as P3, P4, P5) through 144 the microfluidic device ensemble (Methods, Supplementary Fig-9 ). Polaris could retrieve 13, 12 and 32 145 cells from the blood samples of patients P3, P4, P5 respectively. 15 of these 57 cells passed the filtering 146 criteria ( Supplementary Fig-10 ). All 15 cells were classified as CTCs. We used additional validation 147 criteria to determine the carcinogenic origin of the captured cells. When compared to a set of randomly 148 selected PBMCs, ClearCell Polaris captured cells showed elevated expression of breast cancer-specific 149 markers BRCA1 and MDM2 32 (Fig 4-d) . We also detected up-regulation of CDH1, a canonical epithelial Supplementary Fig-11 ).
155
Discussion
156
CTCs have been shown to be of prognostic significance in patients with various cancers 2, 15, 34 . It is While integrating, we found 17609 genes common across 729 CTCs coming from 11 publicly available CTC datasets. After applying the cell and gene filtering steps (as discussed above), we were left with an expression matrix consisting of 14027 genes and 722 CTCs. We constructed a panel of 180 well-known epithelial, mesenchymal, and cancer stem cell markers combining information from the CellMarker database 43 and existing literature. The expression matrix of marker genes thus obtained was subjected to stricter criteria for gene and cell selection. We retained 718 cells that expressed at least 10% of these marker genes. Marker genes having minimum read count >5 in at least 30% of these cells were selected for the subsequent analyses. The resulted matrix consisted of 718 cells and 86 marker genes (16 epithelial, 43 mesenchymal, and 27 cancer stem cell markers, see ( Supplementary Table 2 ). We normalized and log-transformed the matrix as mentioned above. For each cell, we computed a comprehensive score for both epithelial and mesenchymal phenotype. To compute the score we first applied Z-score transformation 5/12 on each cell. To create the signature for specific phenotype, for each cell we combined Z-transformed marker expressions using the below formula.
Here Z phenotype is a comprehensive phenotype specific score computed over individual Z-transformed 194 marker expressions denoted by Z i , where markers denotes the set of markers corresponding to the 195 concerned phenotype.
196
Simulation of E-M continuum 197 We identified the regulatory interactions among epithelial (E) and mesenchymal (M) genes under study, together with their connections to canonical regulators of EMT and MET such as the double negative feedback loops involving miR-200, ZEB and GRHL2 ( Supplementary Note-3) . For the constructed network, an ensemble of mathematical models was then created using RACIPE (RAndom CIrcuit PErturbation), which considers a set of kinetic parameters randomly chosen from within the biologically relevant ranges 44 . This helps to identify the robust gene expression signatures that can emerge due to a given network topology. The simulations were performed in triplets to avoid numerical artifacts/variations due to random sampling. Such ensemble of models are usually based on ordinary differential equations (ODEs), such as the one mentioned below.
where [V IM] is the concentration of VIM, and l V IM and k V IM are its production and degradation log-rank test. We used survminer R package 48 for the survival analyses ( Supplementary Table 3 ). 
